Last checked at 3 May 2018 18:31
GlaxoSmithKline plc
Result of General Meeting
GlaxoSmithKline plc ('GSK') announces that at its General Meeting today, the sole resolution was passed by shareholders. The full text of the resolution is contained in the Circular to Shareholders and Notice of General Meeting which is available on the GSK website at www.gsk.com.
GSK General Meeting Poll Results
The following table shows the total number of votes cast for the resolution:
Resolution | Total votes for* | % | Total votes against | % | Total votes cast | Votes withheld** | |
1 | To approve the buyout of Novartis' interest in GlaxoSmithKline Consumer Healthcare Holdings Limited for the purposes of Chapter 11 of the Listing Rules of the Financial Conduct Authority | 3,886,722,476 | 99.96 | 1,682,767 | 0.04 | 3,888,405,243 | 21,712,896 |
Notes:
* | Includes discretionary votes. |
** | A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "For" or "Against" a resolution. |
The above poll results will shortly be available on the company's website at www.gsk.com.In accordance with Listing Rule 9.6.2, a copy of the resolution will be submitted to the UK Listing Authority and will in due course be available for inspection at www.morningstar.co.uk/uk/NSM
The following table provides further relevant information:
|
General Meeting |
Issued share capital (excluding Treasury Shares) | 4,959,302,644 |
Total votes cast and votes withheld lodged as a % of GSK's issued share capital (excluding Treasury Shares) | 78.84% |
Total shareholder population | 112,326 |
Total number of proxies lodged | 7,976 |
% of shareholders who lodged proxies | 7.10% |
Number of shareholders, corporate representatives and proxies who attended the General Meeting. | 415 |
V A Whyte
Company Secretary
3 May 2018